Immunosuppression and ablastin.
D000225:Adenine / Q000494:pharmacology; D000818:Animals; D000906:Antibodies; D000917:Antibody Formation / Q000187:drug effects; D000961:Antilymphocyte Serum / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D003907:Dexamethasone / Q000494:pharmacology; D005260:Female; D007165:Immunosuppression Therapy; D008297:Male; D015122:Mercaptopurine / Q000494:pharmacology; D051379:Mice; D012157:Mononuclear Phagocyte System / Q000276:immunology; D011247:Pregnancy; D051381:Rats; D012098:Reproduction; D012980:Sodium Salicylate / Q000494:pharmacology; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D013950:Thymus Gland / Q000276:immunology; D014345:Trypanosoma / Q000276:immunology* / Q000378:metabolism / Q000502:physiology; D014352:Trypanosomiasis / Q000276:immunology
D000906:Antibodies; D000961:Antilymphocyte Serum; D003907:Dexamethasone; D003520:Cyclophosphamide; D004247:DNA; D015122:Mercaptopurine; D000225:Adenine; D012980:Sodium Salicylate